{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:51:33Z","timestamp":1792515093709,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05385-3","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:19:26Z","timestamp":1767017966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of human cytomegalovirus in glioblastoma multiforme: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"176","author":[{"given":"Francisco Cezar Aquino de","family":"Moraes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Bartkevitch","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas David de Souza","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Antonia Dups","family":"Talah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rommel Mario Rodr\u00edguez","family":"Burbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Hiroyuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"5385_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00705-019-04206-z","volume":"164","author":"KPRA Farias","year":"2019","unstructured":"Farias KPRA, Moreli ML, Floriano VG, da Costa VG (2019) Evidence based on a meta-analysis of human cytomegalovirus infection in glioma. Arch Virol 164:1249\u20131257. https:\/\/doi.org\/10.1007\/s00705-019-04206-z","journal-title":"Arch Virol"},{"key":"5385_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","volume":"109","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93\u2013108. https:\/\/doi.org\/10.1007\/s00401-005-0991-y","journal-title":"Acta Neuropathol"},{"key":"5385_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41698-024-00709-4","volume":"8","author":"NB Mercado","year":"2024","unstructured":"Mercado NB, Real JN, Kaiserman J, Panagioti E, Cook CH, Lawler SE (2024) Clinical implications of cytomegalovirus in glioblastoma progression and therapy. Npj Precis Onc 8:213. https:\/\/doi.org\/10.1038\/s41698-024-00709-4","journal-title":"Npj Precis Onc Nat Publishing Group"},{"key":"5385_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11033-019-05146-2","volume":"47","author":"H Wang","year":"2020","unstructured":"Wang H, Tang F, Bian E, Zhang Y, Ji X, Yang Z et al (2020) IFITM3\/STAT3 axis promotes glioma cells invasion and is modulated by TGF-\u03b2. Mol Biol Rep 47:433\u2013441. https:\/\/doi.org\/10.1007\/s11033-019-05146-2","journal-title":"Mol Biol Rep"},{"key":"5385_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000531319","volume":"108","author":"A Czarnywojtek","year":"2023","unstructured":"Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J et al (2023) Glioblastoma multiforme: the latest diagnostics and treatment techniques. Pharmacology 108:423\u2013431. https:\/\/doi.org\/10.1159\/000531319","journal-title":"Pharmacology"},{"key":"5385_CR6","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.2010.32.4343","volume":"29","author":"M-YC Polley","year":"2011","unstructured":"Polley M-YC, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M (2011) Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 29:4175\u20134180. https:\/\/doi.org\/10.1200\/JCO.2010.32.4343","journal-title":"J Clin Oncol"},{"key":"5385_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5385_CR8","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.3390\/ijms25115774","volume":"25","author":"K Sadowski","year":"2024","unstructured":"Sadowski K, Ja\u017cd\u017cewska A, Koz\u0142owski J, Zacny A, Lorenc T, Olejarz W (2024) Revolutionizing glioblastoma treatment: A comprehensive overview of modern therapeutic approaches. Int J Mol Sci Multidisciplinary Digit Publishing Inst 25:5774. https:\/\/doi.org\/10.3390\/ijms25115774","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"key":"5385_CR9","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, Lathia JD, Chen P (2024) Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol Nat Publishing Group 21:1354\u20131375. https:\/\/doi.org\/10.1038\/s41423-024-01226-x","journal-title":"Cell Mol Immunol Nat Publishing Group"},{"key":"5385_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s43018-023-00709-6","volume":"5","author":"SJ Bagley","year":"2024","unstructured":"Bagley SJ, Binder ZA, Lamrani L, Marinari E, Desai AS, Nasrallah MP et al (2024) Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nat Cancer 5:517\u2013531. https:\/\/doi.org\/10.1038\/s43018-023-00709-6","journal-title":"Nat Cancer"},{"key":"5385_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11060-024-04881-2","volume":"171","author":"A Badani","year":"2025","unstructured":"Badani A, Ozair A, Khasraw M, Woodworth GF, Tiwari P, Ahluwalia MS et al (2025) Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions. J Neurooncol 171:531\u2013547. https:\/\/doi.org\/10.1007\/s11060-024-04881-2","journal-title":"J Neurooncol"},{"key":"5385_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/jpm15090401","volume":"15","author":"GdaC Nunes","year":"2025","unstructured":"Nunes GdaC, Cezar Aquino de Moraes G, de C\u00e1ssia Calderaro Coelho F, Rodrigues Fernandes R, Emanuel Batista dos Santos M (2025) Pereira Carneiro Dos Santos N. Single-Nucleotide polymorphisms related to glioblastoma risk and worldwide epidemiology: A systematic review and Meta-Analysis. J Personalized Med Multidisciplinary Digit Publishing Inst 15:401. https:\/\/doi.org\/10.3390\/jpm15090401","journal-title":"J Personalized Med Multidisciplinary Digit Publishing Inst"},{"key":"5385_CR13","doi-asserted-by":"publisher","first-page":"960327124124179","DOI":"10.1177\/09603271241241796","volume":"43","author":"CJ Smith","year":"2024","unstructured":"Smith CJ, Perfetti TA, Chokshi C, Venugopal C, Ashford JW, Singh SK (2024) Risk factors for glioblastoma are shared by other brain tumor types. Hum Exp Toxicol 43:9603271241241796. https:\/\/doi.org\/10.1177\/09603271241241796","journal-title":"Hum Exp Toxicol"},{"key":"5385_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12985-025-02826-3","volume":"22","author":"X Wu","year":"2025","unstructured":"Wu X, Zhang Z, Zhang L, Daniels DJ (2025) Role of cytomegalovirus in glioblastoma development: promoter or culprit? Virol J 22:194. https:\/\/doi.org\/10.1186\/s12985-025-02826-3","journal-title":"Virol J"},{"key":"5385_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4161\/hv.27675","volume":"10","author":"V Dasari","year":"2014","unstructured":"Dasari V, Smith C, Schuessler A, Zhong J, Khanna R (2014) Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity. Hum Vaccin Immunother 10:1064\u20131077. https:\/\/doi.org\/10.4161\/hv.27675","journal-title":"Hum Vaccin Immunother"},{"key":"5385_CR16","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1158\/1078-0432.CCR-13-3268","volume":"20","author":"SK Nair","year":"2014","unstructured":"Nair SK, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J et al (2014) Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res 20:2684\u20132694. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3268","journal-title":"Clin Cancer Res"},{"key":"5385_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/cells12040516","volume":"12","author":"I Scheer","year":"2023","unstructured":"Scheer I, Becker I, Schmitter C, Semrau S, Fietkau R, Gaipl US et al (2023) Prospective evaluation of CD45RA+\/CCR7- effector memory T (TEMRA) cell subsets in patients with primary and secondary brain tumors during radiotherapy of the brain within the scope of the prospective Glio-CMV-01 clinical Trial. cells. Multidisciplinary Digit Publishing Inst 12:516. https:\/\/doi.org\/10.3390\/cells12040516","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"5385_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/rmv.1862","volume":"26","author":"L Dupont","year":"2016","unstructured":"Dupont L, Reeves MB (2016) Cytomegalovirus latency and reactivation: recent insights into an age old problem. Rev Med Virol 26:75\u201389. https:\/\/doi.org\/10.1002\/rmv.1862","journal-title":"Rev Med Virol"},{"key":"5385_CR19","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1086\/508173","volume":"43","author":"SAS Staras","year":"2006","unstructured":"Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the united States, 1988\u20131994. Clin Infect Dis 43:1143\u20131151. https:\/\/doi.org\/10.1086\/508173","journal-title":"Clin Infect Dis"},{"key":"5385_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2334-7-71","volume":"7","author":"FAB Colugnati","year":"2007","unstructured":"Colugnati FAB, Staras SAS, Dollard SC, Cannon MJ (2007) Incidence of cytomegalovirus infection among the general population and pregnant women in the united States. BMC Infect Dis 7:71. https:\/\/doi.org\/10.1186\/1471-2334-7-71","journal-title":"BMC Infect Dis"},{"key":"5385_CR21","first-page":"3347","volume":"62","author":"CS Cobbs","year":"2002","unstructured":"Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH et al (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347\u20133350","journal-title":"Cancer Res"},{"key":"5385_CR22","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1111\/nan.12172","volume":"41","author":"E Bianchi","year":"2015","unstructured":"Bianchi E, Roncarati P, Hougrand O, Gu\u00e9rin-El Khourouj V, Boreux R, Kroonen J et al (2015) Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses. Neuropathol Appl Neurobiol 41:e29\u201340. https:\/\/doi.org\/10.1111\/nan.12172","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5385_CR23","doi-asserted-by":"publisher","first-page":"e982391","DOI":"10.4161\/2162402X.2014.982391","volume":"4","author":"A Rahbar","year":"2015","unstructured":"Rahbar A, Peredo I, Solberg NW, Taher C, Dzabic M, Xu X et al (2015) Discordant humoral and cellular immune responses to cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. Oncoimmunology 4:e982391. https:\/\/doi.org\/10.4161\/2162402X.2014.982391","journal-title":"Oncoimmunology"},{"key":"5385_CR24","doi-asserted-by":"publisher","first-page":"642652","DOI":"10.1155\/2015\/642652","volume":"2015","author":"HA Shamran","year":"2015","unstructured":"Shamran HA, Kadhim HS, Hussain AR, Kareem A, Taub DD, Price RL et al (2015) Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients. Biomed Res Int 2015:642652. https:\/\/doi.org\/10.1155\/2015\/642652","journal-title":"Biomed Res Int"},{"key":"5385_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-015-1905-z","volume":"125","author":"A Wakefield","year":"2015","unstructured":"Wakefield A, Pignata A, Ghazi A, Ashoori A, Hegde M, Landi D et al (2015) Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients. J Neurooncol 125:307\u2013315. https:\/\/doi.org\/10.1007\/s11060-015-1905-z","journal-title":"J Neurooncol"},{"key":"5385_CR26","doi-asserted-by":"publisher","first-page":"e0159604","DOI":"10.1371\/journal.pone.0159604","volume":"11","author":"LM Stangherlin","year":"2016","unstructured":"Stangherlin LM, Castro FLF, Medeiros RSS, Guerra JM, Kimura LM, Shirata NK et al (2016) Human cytomegalovirus DNA quantification and gene expression in gliomas of different grades. PLoS ONE 11:e0159604. https:\/\/doi.org\/10.1371\/journal.pone.0159604","journal-title":"PLoS ONE"},{"key":"5385_CR27","doi-asserted-by":"publisher","first-page":"101042831771251","DOI":"10.1177\/1010428317712512","volume":"39","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhao P, Qian D, Hu M, Zhang L, Shi H et al (2017) MicroRNA-613 is downregulated in HCMV-positive glioblastoma and inhibits tumour progression by targeting arginase-2. Tumour Biol 39:1010428317712512. https:\/\/doi.org\/10.1177\/1010428317712512","journal-title":"Tumour Biol"},{"key":"5385_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13238-020-00696-9","volume":"11","author":"L Wen","year":"2020","unstructured":"Wen L, Zhao F, Qiu Y, Cheng S, Sun J-Y, Fang W et al (2020) Human cytomegalovirus DNA and immediate early protein 1\/2 are highly associated with glioma and prognosis. Protein Cell 11:525\u2013533. https:\/\/doi.org\/10.1007\/s13238-020-00696-9","journal-title":"Protein Cell"},{"key":"5385_CR29","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1172\/JCI123375","volume":"129","author":"H Krenzlin","year":"2019","unstructured":"Krenzlin H, Behera P, Lorenz V, Passaro C, Zdioruk M, Nowicki MO et al (2019) Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis. J Clin Invest 129:1671\u20131683. https:\/\/doi.org\/10.1172\/JCI123375","journal-title":"J Clin Invest"},{"key":"5385_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","volume":"52","author":"M Zapatka","year":"2020","unstructured":"Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M et al (2020) The landscape of viral associations in human cancers. Nat Genet 52:320\u2013330. https:\/\/doi.org\/10.1038\/s41588-019-0558-9","journal-title":"Nat Genet"},{"key":"5385_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-9378-10-3","volume":"10","author":"Y Hashida","year":"2015","unstructured":"Hashida Y, Taniguchi A, Yawata T, Hosokawa S, Murakami M, Hiroi M et al (2015) Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect Agent Cancer 10:3. https:\/\/doi.org\/10.1186\/1750-9378-10-3","journal-title":"Infect Agent Cancer"},{"key":"5385_CR32","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-12-3846","volume":"73","author":"RL Price","year":"2013","unstructured":"Price RL, Song J, Bingmer K, Kim TH, Yi J-Y, Nowicki MO et al (2013) Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res 73:3441\u20133450. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3846","journal-title":"Cancer Res"},{"key":"5385_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK-L Lo","year":"2014","unstructured":"Lo CK-L, Mertz D, Loeb M (2014) Newcastle-Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol 14:45. https:\/\/doi.org\/10.1186\/1471-2288-14-45","journal-title":"BMC Med Res Methodol"},{"key":"5385_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR (2018) A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc 16:195\u2013203. https:\/\/doi.org\/10.1097\/XEB.0000000000000141","journal-title":"Int J Evid Based Healthc"},{"key":"5385_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"5385_CR36","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"5385_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12032-014-0252-9","volume":"31","author":"N Ahani","year":"2014","unstructured":"Ahani N, Shirkoohi R, Rokouei M, Alipour Eskandani M, Nikravesh A (2014) Overexpression of enhancer of Zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues. Med Oncol 31:252. https:\/\/doi.org\/10.1007\/s12032-014-0252-9","journal-title":"Med Oncol"},{"key":"5385_CR38","unstructured":"Chen T-Q, Li Z-X, Jiang Y, Xu X-D, Gan L, Wang B-L Detection of human cytomegalovirus in tumor tissue and peripheral blood samples of patients with gliomas"},{"key":"5385_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11060-013-1350-9","volume":"116","author":"D Ding","year":"2014","unstructured":"Ding D, Han S, Wang Z, Guo Z, Wu A (2014) Does the existence of HCMV components predict poor prognosis in glioma? J Neurooncol 116:515\u2013522. https:\/\/doi.org\/10.1007\/s11060-013-1350-9","journal-title":"J Neurooncol"},{"key":"5385_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.18683\/germs.2022.1304","volume":"12","author":"C Fall","year":"2022","unstructured":"Fall C, Faiz MCE, Hammass N, Fatemi HE, Hassouni K, Bouguenouch L et al (2022) Human cytomegalovirus and isocitrate dehydrogenase status in glioma: association and prognosis value in Moroccan population. Germs 12:32\u201345. https:\/\/doi.org\/10.18683\/germs.2022.1304","journal-title":"Germs"},{"key":"5385_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1590\/s0074-02762012000700020","volume":"107","author":"RF Fonseca","year":"2012","unstructured":"Fonseca RF, Kawamura MT, Oliveira JA, Teixeira A, Alves G, Carvalho M (2012) Da G Da C. The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients. Mem Inst Oswaldo Cruz 107:953\u2013954. https:\/\/doi.org\/10.1590\/s0074-02762012000700020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5385_CR42","doi-asserted-by":"publisher","first-page":"vdz020","DOI":"10.1093\/noajnl\/vdz020","volume":"1","author":"H Foster","year":"2019","unstructured":"Foster H, Piper K, DePledge L, Li H-F, Scanlan J, Jae-Guen Y et al (2019) Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients. Neurooncol Adv 1:vdz020. https:\/\/doi.org\/10.1093\/noajnl\/vdz020","journal-title":"Neurooncol Adv"},{"key":"5385_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4149\/neo_2018_170124N59","volume":"65","author":"S Han","year":"2018","unstructured":"Han S, Wang PF, Xing YX, Song HW, Yao K, Lin ZX (2018) Human cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas. Neoplasma 65:431\u2013435. https:\/\/doi.org\/10.4149\/neo_2018_170124N59","journal-title":"Neoplasma"},{"key":"5385_CR44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/07357907.2020.1793352","volume":"38","author":"S Limam","year":"2020","unstructured":"Limam S, Missaoui N, Hmissa S, Yacoubi MT, Krifa H, Mokni M et al (2020) Investigation of human cytomegalovirus and human papillomavirus in glioma. Cancer Invest 38:394\u2013405. https:\/\/doi.org\/10.1080\/07357907.2020.1793352","journal-title":"Cancer Invest"},{"key":"5385_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13365-018-0683-8","volume":"25","author":"M-P Loit","year":"2019","unstructured":"Loit M-P, Adle-Biassette H, Bouazza S, Mazeron M-C, Manivet P, Lehmann-Che J et al (2019) Multimodal techniques failed to detect cytomegalovirus in human glioblastoma samples. J Neurovirol 25:50\u201356. https:\/\/doi.org\/10.1007\/s13365-018-0683-8","journal-title":"J Neurovirol"},{"key":"5385_CR46","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/jmv.25673","volume":"92","author":"F Maleki","year":"2020","unstructured":"Maleki F, Sadigh Z-A, Sadeghi F, Muhammadnejad A, Farahmand M, Parvin M et al (2020) Human cytomegalovirus infection in Iranian glioma patients correlates with aging and tumor aggressiveness. J Med Virol 92:1266\u20131276. https:\/\/doi.org\/10.1002\/jmv.25673","journal-title":"J Med Virol"},{"key":"5385_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1215\/15228517-2007-035","volume":"10","author":"DA Mitchell","year":"2008","unstructured":"Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE et al (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10:10\u201318. https:\/\/doi.org\/10.1215\/15228517-2007-035","journal-title":"Neuro Oncol"},{"key":"5385_CR48","doi-asserted-by":"publisher","unstructured":"Peredo-Harvey I, Bartek J, Ericsson C, Yaiw K-C, Nist\u00e9r M, Rahbar A et al (2023) Higher human cytomegalovirus (HCMV) specific IgG antibody levels in plasma samples from patients with metastatic brain tumors are associated with longer Survival. Medicina, vol 59. Multidisciplinary Digital Publishing Institute, p 1248. https:\/\/doi.org\/10.3390\/medicina59071248","DOI":"10.3390\/medicina59071248"},{"key":"5385_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jcv.2012.12.018","volume":"57","author":"A Rahbar","year":"2013","unstructured":"Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Str\u00e5\u00e5t K et al (2013) Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol 57:36\u201342. https:\/\/doi.org\/10.1016\/j.jcv.2012.12.018","journal-title":"J Clin Virol"},{"key":"5385_CR50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/sj.bjc.6602339","volume":"92","author":"J Sabatier","year":"2005","unstructured":"Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tr\u00e9moulet M et al (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747\u2013750. https:\/\/doi.org\/10.1038\/sj.bjc.6602339","journal-title":"Br J Cancer"},{"key":"5385_CR51","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/jmv.23820","volume":"86","author":"CJ dos Santos","year":"2014","unstructured":"dos Santos CJ, Stangherlin LM, Figueiredo EG, Corr\u00eaa C, Teixeira MJ, da Silva MCC (2014) High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol 86:1953\u20131961. https:\/\/doi.org\/10.1002\/jmv.23820","journal-title":"J Med Virol"},{"key":"5385_CR52","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/ijc.28111","volume":"133","author":"G Stragliotto","year":"2013","unstructured":"Stragliotto G, Rahbar A, Solberg NW, Lilja A, Taher C, Orrego A et al (2013) Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer 133:1204\u20131213. https:\/\/doi.org\/10.1002\/ijc.28111","journal-title":"Int J Cancer"},{"key":"5385_CR53","doi-asserted-by":"publisher","first-page":"e0179366","DOI":"10.1371\/journal.pone.0179366","volume":"12","author":"C-F Yang","year":"2017","unstructured":"Yang C-F, Ho H-L, Lin S-C, Hsu C-Y, Ho DM-T (2017) Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects. PLoS ONE 12:e0179366. https:\/\/doi.org\/10.1371\/journal.pone.0179366","journal-title":"PLoS ONE"},{"key":"5385_CR54","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.prp.2016.12.006","volume":"213","author":"S Zavala-Vega","year":"2017","unstructured":"Zavala-Vega S, Castro-Escarpulli G, Hern\u00e1ndez-Santos H, Salinas-Lara C, Palma I, Mej\u00eda-Arangur\u00e9 JM et al (2017) An overview of the infection of CMV, HSV 1\/2 and EBV in Mexican patients with glioblastoma multiforme. Pathol - Res Pract 213:271\u2013276. https:\/\/doi.org\/10.1016\/j.prp.2016.12.006","journal-title":"Pathol - Res Pract"},{"key":"5385_CR55","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5603\/RPOR.a2022.0113","volume":"27","author":"S Mohammed","year":"2022","unstructured":"Mohammed S, Dinesan M, Ajayakumar T (2022) Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. Rep Pract Oncol Radiother 27:1026\u20131036. https:\/\/doi.org\/10.5603\/RPOR.a2022.0113","journal-title":"Rep Pract Oncol Radiother"},{"key":"5385_CR56","doi-asserted-by":"publisher","unstructured":"Davis ME, Glioblastoma (2016) Overview of disease and treatment. Clin J Oncol Nurs 20. https:\/\/doi.org\/10.1188\/16.CJON.S1.2-8. S2-8","DOI":"10.1188\/16.CJON.S1.2-8"},{"key":"5385_CR57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","volume":"24","author":"A Pouyan","year":"2025","unstructured":"Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A et al (2025) Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. Mol Cancer 24:58. https:\/\/doi.org\/10.1186\/s12943-025-02267-0","journal-title":"Mol Cancer"},{"key":"5385_CR58","doi-asserted-by":"publisher","unstructured":"Herbein G (2018) The human Cytomegalovirus, from oncomodulation to Oncogenesis. Viruses. 10:408. https:\/\/doi.org\/10.3390\/v10080408. Multidisciplinary Digital Publishing Institute","DOI":"10.3390\/v10080408"},{"key":"5385_CR59","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41418-022-00953-w","volume":"29","author":"JM Merchut-Maya","year":"2022","unstructured":"Merchut-Maya JM, Bartek J, Bartkova J, Galanos P, Pantalone MR, Lee M et al (2022) Human cytomegalovirus hijacks host stress response fueling replication stress and genome instability. Cell Death Differ 29:1639\u20131653. https:\/\/doi.org\/10.1038\/s41418-022-00953-w","journal-title":"Cell Death Differ"},{"key":"5385_CR60","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/cam4.682","volume":"5","author":"ES Amirian","year":"2016","unstructured":"Amirian ES, Scheurer ME, Zhou R, Wrensch MR, Armstrong GN, Lachance D et al (2016) History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer Med 5:1352\u20131358. https:\/\/doi.org\/10.1002\/cam4.682","journal-title":"Cancer Med"},{"key":"5385_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2042-4280-3-3","volume":"3","author":"A Rahbar","year":"2012","unstructured":"Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J et al (2012) Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; -a case-control study. Herpesviridae 3:3. https:\/\/doi.org\/10.1186\/2042-4280-3-3","journal-title":"Herpesviridae"},{"key":"5385_CR62","doi-asserted-by":"crossref","unstructured":"Hudock TR, Song JJ, Chobrutskiy A, Chobrutskiy BI, Blanck G (2024) IGH Complementarity determining region-3-cytomegalovirus protein chemical complementarity linked to better overall survival probabilities for glioblastoma. PubMed [Internet]. [cited 2025 Dec 12]; https:\/\/pubmed.ncbi.nlm.nih.gov\/38848306\/. Accessed 12 Dec 2025","DOI":"10.1089\/vim.2024.0013"},{"key":"5385_CR63","unstructured":"G G, Hm LM, T H, Am R, Jl M et al (2023) W,. Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma. PubMed [Internet]. [cited 2025 Dec 12]; https:\/\/pubmed.ncbi.nlm.nih.gov\/36610073\/. Accessed 12 Dec 2025"},{"key":"5385_CR64","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1126\/science.1152095","volume":"320","author":"AJ Hume","year":"2008","unstructured":"Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF (2008) Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797\u2013799. https:\/\/doi.org\/10.1126\/science.1152095","journal-title":"Science"},{"key":"5385_CR65","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.1128\/jvi.74.17.8028-8037.2000","volume":"74","author":"JP Castillo","year":"2000","unstructured":"Castillo JP, Yurochko AD, Kowalik TF (2000) Role of human cytomegalovirus immediate-early proteins in cell growth control. J Virol 74:8028\u20138037. https:\/\/doi.org\/10.1128\/jvi.74.17.8028-8037.2000","journal-title":"J Virol"},{"key":"5385_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","volume":"30","author":"A Kumar","year":"2018","unstructured":"Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L et al (2018) The human cytomegalovirus strain DB activates oncogenic pathways in mammary epithelial cells. EBioMedicine 30:167\u2013183. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.015","journal-title":"EBioMedicine"},{"key":"5385_CR67","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jnci\/djp031","volume":"101","author":"K Str\u00e5\u00e5t","year":"2009","unstructured":"Str\u00e5\u00e5t K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N et al (2009) Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 101:488\u2013497. https:\/\/doi.org\/10.1093\/jnci\/djp031","journal-title":"J Natl Cancer Inst"},{"key":"5385_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/med.20018","volume":"25","author":"J Cinatl","year":"2005","unstructured":"Cinatl J, Scholz M, Doerr HW (2005) Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation. Med Res Rev 25:167\u2013185. https:\/\/doi.org\/10.1002\/med.20018","journal-title":"Med Res Rev"},{"key":"5385_CR69","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1038\/s41388-018-0255-7","volume":"37","author":"R Heukers","year":"2018","unstructured":"Heukers R, Fan TS, de Wit RH, van Senten JR, De Groof TWM, Bebelman MP et al (2018) The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth. Oncogene 37:4110\u20134121. https:\/\/doi.org\/10.1038\/s41388-018-0255-7","journal-title":"Oncogene"},{"key":"5385_CR70","doi-asserted-by":"publisher","first-page":"16297","DOI":"10.1074\/jbc.RA119.007796","volume":"294","author":"JR van Senten","year":"2019","unstructured":"van Senten JR, Bebelman MP, Fan TS, Heukers R, Bergkamp ND, van Gasselt P et al (2019) The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties. J Biol Chem 294:16297\u201316308. https:\/\/doi.org\/10.1074\/jbc.RA119.007796","journal-title":"J Biol Chem"},{"key":"5385_CR71","doi-asserted-by":"publisher","first-page":"67966","DOI":"10.18632\/oncotarget.11817","volume":"7","author":"RH de Wit","year":"2016","unstructured":"de Wit RH, Muji\u0107-Deli\u0107 A, van Senten JR, Fraile-Ramos A, Siderius M, Smit MJ (2016) Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1\u03b1\/PKM2 axis in glioblastoma cells. Oncotarget 7:67966\u201367985. https:\/\/doi.org\/10.18632\/oncotarget.11817","journal-title":"Oncotarget"},{"key":"5385_CR72","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2042-4280-1-2","volume":"1","author":"J Vomaske","year":"2010","unstructured":"Vomaske J, Varnum S, Melnychuk R, Smith P, Pasa-Tolic L, Shutthanandan JI et al (2010) HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase. Herpesviridae 1:2. https:\/\/doi.org\/10.1186\/2042-4280-1-2","journal-title":"Herpesviridae"},{"key":"5385_CR73","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1134\/S0026893322050132","volume":"56","author":"GR Vinogradskaya","year":"2022","unstructured":"Vinogradskaya GR, Ivanov AV, Kushch AA (2022) Mechanisms of survival of Cytomegalovirus-Infected tumor cells. Mol Biol 56:668\u2013683. https:\/\/doi.org\/10.1134\/S0026893322050132","journal-title":"Mol Biol"},{"key":"5385_CR74","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/neuonc\/noac283","volume":"25","author":"G Guerra","year":"2023","unstructured":"Guerra G, McCoy L, Hansen HM, Rice T, Molinaro AM, Wiemels JL et al (2023) Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma. Neuro Oncol 25:1047\u20131057. https:\/\/doi.org\/10.1093\/neuonc\/noac283","journal-title":"Neuro Oncol"},{"key":"5385_CR75","doi-asserted-by":"publisher","first-page":"e1007569","DOI":"10.1371\/journal.ppat.1007569","volume":"15","author":"I Rodr\u00edguez-S\u00e1nchez","year":"2019","unstructured":"Rodr\u00edguez-S\u00e1nchez I, Schafer XL, Monaghan M, Munger J (2019) The human cytomegalovirus UL38 protein drives mTOR-independent metabolic flux reprogramming by inhibiting TSC2. PLoS Pathog 15:e1007569. https:\/\/doi.org\/10.1371\/journal.ppat.1007569","journal-title":"PLoS Pathog"},{"key":"5385_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1423-0127-16-107","volume":"16","author":"V-K Siew","year":"2009","unstructured":"Siew V-K, Duh C-Y, Wang S-K (2009) Human cytomegalovirus UL76 induces chromosome aberrations. J Biomed Sci 16:107. https:\/\/doi.org\/10.1186\/1423-0127-16-107","journal-title":"J Biomed Sci"},{"key":"5385_CR77","doi-asserted-by":"publisher","first-page":"eade6737","DOI":"10.1126\/scisignal.ade6737","volume":"16","author":"ND Bergkamp","year":"2023","unstructured":"Bergkamp ND, van Senten JR, Brink HJ, Bebelman MP, van den Bor J, \u00c7obano\u011flu TS et al (2023) A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis. Sci Signal 16:eade6737. https:\/\/doi.org\/10.1126\/scisignal.ade6737","journal-title":"Sci Signal"},{"key":"5385_CR78","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature07209","volume":"455","author":"L Soroceanu","year":"2008","unstructured":"Soroceanu L, Akhavan A, Cobbs CS (2008) Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455:391\u2013395. https:\/\/doi.org\/10.1038\/nature07209","journal-title":"Nature"},{"key":"5385_CR79","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M (2004) PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev 30:193\u2013204. https:\/\/doi.org\/10.1016\/j.ctrv.2003.07.007","journal-title":"Cancer Treat Rev"},{"key":"5385_CR80","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/0008-5472.CAN-07-2291","volume":"68","author":"CS Cobbs","year":"2008","unstructured":"Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH (2008) Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res. 2008;68:724\u2013730. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2291","journal-title":"Cancer Res"},{"key":"5385_CR81","doi-asserted-by":"publisher","first-page":"ra58","DOI":"10.1126\/scisignal.2001180","volume":"3","author":"E Slinger","year":"2010","unstructured":"Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A et al (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3:ra58. https:\/\/doi.org\/10.1126\/scisignal.2001180","journal-title":"Sci Signal"},{"key":"5385_CR82","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-11-0744","volume":"71","author":"L Soroceanu","year":"2011","unstructured":"Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, Greene M et al (2011) Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res 71:6643\u20136653. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0744","journal-title":"Cancer Res"},{"key":"5385_CR83","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.canlet.2021.05.005","volume":"513","author":"H Krenzlin","year":"2021","unstructured":"Krenzlin H, Zdioruk M, Nowicki MO, Finkelberg T, Keric N, Lemmermann N et al (2021) Cytomegalovirus infection of glioblastoma cells leads to NF-\u03baB dependent upregulation of the c-MET oncogenic tyrosine kinase. Cancer Lett 513:26\u201335. https:\/\/doi.org\/10.1016\/j.canlet.2021.05.005","journal-title":"Cancer Lett"},{"key":"5385_CR84","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fnagi.2017.00352","volume":"9","author":"H Xu","year":"2017","unstructured":"Xu H, Chen J, Xu H, Qin Z (2017) Geographic variations in the incidence of glioblastoma and prognostic factors predictive of overall survival in US adults from 2004\u20132013. Front Aging Neurosci 9:352. https:\/\/doi.org\/10.3389\/fnagi.2017.00352","journal-title":"Front Aging Neurosci"},{"key":"5385_CR85","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41417-024-00746-y","volume":"31","author":"Y-F Huang","year":"2024","unstructured":"Huang Y-F, Chiao M-T, Hsiao T-H, Zhan Y-X, Chen T-Y, Lee C-H et al (2024) Genetic mutation patterns among glioblastoma patients in the Taiwanese population \u2013 insights from a single institution retrospective study. Cancer Gene Ther Nat Publishing Group 31:894\u2013903. https:\/\/doi.org\/10.1038\/s41417-024-00746-y","journal-title":"Cancer Gene Ther Nat Publishing Group"},{"key":"5385_CR86","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12029-025-01305-w","volume":"56","author":"FCA de Moraes","year":"2025","unstructured":"de Moraes FCA, Matheus GTFU, Sobreira LER, Lam SJ, Reis MR, Burbano RMR (2025) Global epidemiology of PD-L1 expression in Epstein-Barr Virus-Associated gastric cancer: A systematic review and Meta-Analysis. J Gastrointest Canc 56:178. https:\/\/doi.org\/10.1007\/s12029-025-01305-w","journal-title":"J Gastrointest Canc"},{"key":"5385_CR87","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.18632\/oncotarget.27016","volume":"10","author":"CS Naucl\u00e9r","year":"2019","unstructured":"Naucl\u00e9r CS, Geisler J, Vetvik K (2019) The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications. Oncotarget 10:4333\u20134347. https:\/\/doi.org\/10.18632\/oncotarget.27016","journal-title":"Oncotarget"},{"key":"5385_CR88","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/microorganisms8101471","volume":"8","author":"G Stragliotto","year":"2020","unstructured":"Stragliotto G, Pantalone MR, Rahbar A, S\u00f6derberg-Naucl\u00e9r C (2020) Valganciclovir as add-on to standard therapy in secondary glioblastoma. Microorganisms 8:1471. https:\/\/doi.org\/10.3390\/microorganisms8101471","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"5385_CR89","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1158\/1078-0432.CCR-20-0369","volume":"26","author":"G Stragliotto","year":"2020","unstructured":"Stragliotto G, Pantalone MR, Rahbar A, Bartek J, S\u00f6derberg-Naucler C (2020) Valganciclovir as Add-on to standard therapy in glioblastoma patients. Clin Cancer Res 26:4031\u20134039. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0369","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05385-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:06Z","timestamp":1769773626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05385-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5385"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05385-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. All methods were carried out in accordance with relevant guidelines and regulations. Ethical approval and informed consent were therefore not required for this systematic review and meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. This study did not involve any experiments on humans or animals, nor the use of identifiable personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors received payments or services via his or her institution or from third parties.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}